Pegylated liposomal doxorubicin (PLD) as an alternative treatment of cutaneous T-cell lymphoma

8096 Background: Therapy of cutaneous T-cell lymphoma (CTCL) at early stages consists of various modalities. The advanced or transformed stage of CTCL is treated by the CHOP regimen as standard che...